AT7867 Is a Potent and Oral Inhibitor of AKT and p70 S6 Kinase That Induces Pharmacodynamic Changes and Inhibits Human Tumor Xenograft Growth-Reference-Cited by-同舟云学术

AT7867 Is a Potent and Oral Inhibitor of AKT and p70 S6 Kinase That Induces Pharmacodynamic Changes and Inhibits Human Tumor Xenograft Growth

Published:2010-04-27 Issue:5 Volume:9 Page:1100-1110
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Grimshaw Kyla M.,Hunter Lisa-Jane K.,Yap Timothy A.,Heaton Simon P.,Walton Mike I.,Woodhead Steven J.,Fazal Lynsey,Reule Matthias,Davies Thomas G.,Seavers Lisa C.,Lock Victoria,Lyons John F.,Thompson Neil T.,Workman Paul,Garrett Michelle D.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Attention Mechanism-Based Graph Neural Network Model for Effective Activity Prediction of SARS-CoV-2 Main Protease Inhibitors: Application to Drug Repurposing as Potential COVID-19 Therapy;Journal of Chemical Information and Modeling;2023-11-14

2. Molecular insights into the behavior of the allosteric and ATP-competitive inhibitors in interaction with AKT1 protein: A molecular dynamics study;International Journal of Biological Macromolecules;2023-07

3. AT7867 Inhibits the Growth of Colorectal Cancer Stem-Like Cells and Stemness by Regulating the Stem Cell Maintenance Factor Ascl2 and Akt Signaling;Stem Cells International;2023-02-14

4. Enhanced compound-protein binding affinity prediction by representing protein multimodal information via a coevolutionary strategy;Briefings in Bioinformatics;2023-01-22

5. Recent advances in PI3K/PKB/mTOR inhibitors as new anticancer agents;European Journal of Medicinal Chemistry;2023-01